Naari Pharma Private Limited, a active private limited company, was established on 23 February 1978 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899KA1978PTC142872. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹86.83 Cr and a paid-up capital of ₹2.70 Cr.
Formerly known as Indo Phyto Chemicals Private Limited. It upholds a compliant status. Employing 186 professional, Its leadership includes Hermann Osterwald (Nominee Director), Prithipal Singh Kochhar (Whole-Time Director), Pudhucode Radhakrishnan Kannan (Nominee Director). Past directors included Jagtaran Singh Kochhar, Alex Francis Fernandes, Anil Mohan Puri. It holds ₹104.50 Cr open charges and ₹185.45 Cr settled loans. Its latest AGM occurred on 12 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.30, Galaxy, 1St Main Road Jp Nagar, Third Phase, Bangalore, Karnataka, 560078.
U74899KA1978PTC142872
142872
23 February 1978
₹86.83 Cr
₹2.70 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Naari Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hermann Osterwald | Nominee Director | 30 Sep 2020 | Current |
| Prithipal Singh Kochhar | Whole-Time Director | 15 Apr 2015 | Current |
| Pudhucode Radhakrishnan Kannan | Nominee Director | 24 Jul 2025 | Current |
| Deepak Komaregowda | Nominee Director | 06 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Director | 27 Jan 2016 | Past |
| Pramod Abcsdd | Director | 12 Feb 2016 | Past |
| Pramod Abcsdd | Director | 27 Jan 2016 | Past |
| Pramod Abcsdd | Director | 26 Jan 2016 | Past |
| Pramod Abcsdd | Director | 17 Apr 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Naari Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 17.72% increase. The company also saw a substantial improvement in profitability, with a 149.28% increase in profit. The company's net worth Soared by an impressive increase of 29.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Naari Pharma had a promoter holding of 74.40% and a public holding of 25.59%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,045,000,000.00
₹1,854,475,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2022 | Tata Capital Financial Services Limited | ₹2.00 Cr | Open |
| 27 Dec 2021 | Tata Capital Financial Services Limited | ₹4.00 Cr | Open |
| 30 Sep 2021 | Hdfc Bank Limited | ₹44.50 Cr | Open |
| 17 Feb 2020 | Others | ₹30.00 Cr | Open |
| 29 Nov 2019 | Tata Capital Financial Services Limited | ₹24.00 Cr | Open |
Explore comprehensive loan charge details -
Naari Pharma has a workforce of 186 employees as of Mar 05, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Naari Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naari Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 30.00 Cr registered on 17 Feb 2020 with Charge ID 100330199 was modified on 21 Aug 2025. was recorded as a recent event.
Progress on Naari Pharma Private Limited last Annual general meeting of members was held on 12 Aug 2025 as per latest MCA records. was documented.
Pudhucode Radhakrishnan Kannan was appointed as a Nominee Director was appointed as a Nominee Director on 24 Jul 2025 & has been associated with this company since 5 months 3 days . was recorded as a recent event.
Naari Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
The activity Prashanth Bhaskar was appointed as a Cfo was appointed as a Cfo on 09 Oct 2024 & has been associated with this company since 1 year 2 months . was completed.
The activity A charge registered on 27 Dec 2022 via Charge ID 100688889 with Others was fully satisfied on 21 Mar 2024. was completed.
The CIN of Naari Pharma Private Limited is U74899KA1978PTC142872.
Naari Pharma Private Limited is headquartered at Plot No.30, Galaxy, 1St Main Road Jp Nagar, Third Phase, Bangalore, Karnataka, 560078.
Naari Pharma Private Limited was incorporated on 23 February 1978.
The current directors of Naari Pharma Private Limited are
The primary industry of Naari Pharma Private Limited is Manufacturing.
Naari Pharma Private Limited is unlisted.
The authorized capital of Naari Pharma Private Limited is ₹86.83 Cr, and the paid-up capital is ₹2.70 Cr.
The compliance status of Naari Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX